NEUROBO PHARMACEUTICALS APPOINTS HYUNG HEON KIM AS CHIEF EXECUTIVE OFFICER AND PRESIDENT
BOSTON, Aug. 14, 2023 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. , a clinical-stage biotechnology company on a quest to transform cardiometabolic diseases, today announced the appointment of... -Today at 08:02 am- MarketScreener
Source: marketscreener.com